{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T04:50:44Z","timestamp":1777783844080,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,18]]},"DOI":"10.7759\/cureus.101784","type":"journal-article","created":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T14:28:40Z","timestamp":1768746520000},"source":"Crossref","is-referenced-by-count":1,"title":["Systemic Sclerosis-Related Intestinal Pseudo-Obstruction Mimicking Mechanical Small Bowel Obstruction"],"prefix":"10.7759","author":[{"given":"Anaan","family":"Fareed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joel","family":"Petit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01692-0","article-title":"Systemic sclerosis","volume":"401","author":"Volkmann ER","year":"2023","unstructured":"Volkmann ER, Andr\u00e9asson K, Smith V. Systemic sclerosis. Lancet. 2023, 401:304-18. 10.1016\/S0140-6736(22)01692-0","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0755-4982(06)74930-2","article-title":"Gastrointestinal involvement in systemic sclerosis. [Article in French]","volume":"2","author":"Marie I","year":"2006","unstructured":"Marie I. Gastrointestinal involvement in systemic sclerosis. [Article in French]. Presse Med. 2006, 2:1952-65. 10.1016\/s0755-4982(06)74930-2","journal-title":"Presse Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00900-6","article-title":"Systemic sclerosis gastrointestinal dysmotility: risk factors, pathophysiology, diagnosis and management","volume":"19","author":"McMahan ZH","year":"2023","unstructured":"McMahan ZH, Kulkarni S, Chen J, Chen JZ, Xavier RJ, Pasricha PJ, Khanna D. Systemic sclerosis gastrointestinal dysmotility: risk factors, pathophysiology, diagnosis and management. Nat Rev Rheumatol. 2023, 19:166-81. 10.1038\/s41584-022-00900-6","journal-title":"Nat Rev Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev393","article-title":"Intestinal pseudo-obstruction in patients with systemic sclerosis: an analysis of the Nationwide Inpatient Sample","volume":"55","author":"Valenzuela A","year":"2016","unstructured":"Valenzuela A, Li S, Becker L, Fernandez-Becker N, Khanna D, Nguyen L, Chung L. Intestinal pseudo-obstruction in patients with systemic sclerosis: an analysis of the Nationwide Inpatient Sample. Rheumatology (Oxford). 2016, 55:654-8. 10.1093\/rheumatology\/kev393","journal-title":"Rheumatology (Oxford)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.131547","article-title":"Mortality, recurrence, and hospital course of patients with systemic sclerosis-related acute intestinal pseudo-obstruction","volume":"41","author":"Mecoli C","year":"2014","unstructured":"Mecoli C, Purohit S, Sandorfi N, Derk CT. Mortality, recurrence, and hospital course of patients with systemic sclerosis-related acute intestinal pseudo-obstruction. J Rheumatol. 2014, 41:2049-54. 10.3899\/jrheum.131547","journal-title":"J Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2017.07.019","article-title":"Role of anti-receptor autoantibodies in pathophysiology of scleroderma","volume":"16","author":"Berger M","year":"2017","unstructured":"Berger M, Steen VD. Role of anti-receptor autoantibodies in pathophysiology of scleroderma. Autoimmun Rev. 2017, 16:1029-35. 10.1016\/j.autrev.2017.07.019","journal-title":"Autoimmun Rev"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13963","article-title":"Review article: pathogenesis and clinical manifestations of gastrointestinal involvement in systemic sclerosis","volume":"45","author":"Kumar S","year":"2017","unstructured":"Kumar S, Singh J, Rattan S, DiMarino AJ, Cohen S, Jimenez SA. Review article: pathogenesis and clinical manifestations of gastrointestinal involvement in systemic sclerosis. Aliment Pharmacol Ther. 2017, 45:883-98. 10.1111\/apt.13963","journal-title":"Aliment Pharmacol Ther"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.5.675","article-title":"Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults","volume":"41","author":"Mann SD","year":"1997","unstructured":"Mann SD, Debinski HS, Kamm MA. Clinical characteristics of chronic idiopathic intestinal pseudo-obstruction in adults. Gut. 1997, 41:675-81. 10.1136\/gut.41.5.675","journal-title":"Gut"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/acem.12150","article-title":"Adult small bowel obstruction","volume":"20","author":"Taylor MR","year":"2013","unstructured":"Taylor MR, Lalani N. Adult small bowel obstruction. Acad Emerg Med. 2013, 20:528-44. 10.1111\/acem.12150","journal-title":"Acad Emerg Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/ans.13148","article-title":"Acute and chronic pseudo-obstruction: a current update","volume":"85","author":"Bernardi MP","year":"2015","unstructured":"Bernardi MP, Warrier S, Lynch AC, Heriot AG. Acute and chronic pseudo-obstruction: a current update. ANZ J Surg. 2015, 85:709-14. 10.1111\/ans.13148","journal-title":"ANZ J Surg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-008-0913-1","article-title":"Chronic intestinal pseudo-obstruction in adult patients: multidetector row helical CT features","volume":"18","author":"Merlin A","year":"2008","unstructured":"Merlin A, Soyer P, Boudiaf M, Hamzi L, Rymer R. Chronic intestinal pseudo-obstruction in adult patients: multidetector row helical CT features. Eur Radiol. 2008, 18:1587-95. 10.1007\/s00330-008-0913-1","journal-title":"Eur Radiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-017-0566-9","article-title":"A systematic review of the clinical presentation, diagnosis, and treatment of small bowel obstruction","volume":"19","author":"Reddy SR","year":"2017","unstructured":"Reddy SR, Cappell MS. A systematic review of the clinical presentation, diagnosis, and treatment of small bowel obstruction. Curr Gastroenterol Rep. 2017, 19:10.1007\/s11894-017-0566-9","journal-title":"Curr Gastroenterol Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0226740","article-title":"Diagnostic utility of CT for small bowel obstruction: systematic review and meta-analysis","volume":"14","author":"Li Z","year":"2019","unstructured":"Li Z, Zhang L, Liu X, Yuan F, Song B. Diagnostic utility of CT for small bowel obstruction: systematic review and meta-analysis. PLoS One. 2019, 14:10.1371\/journal.pone.0226740","journal-title":"PLoS One"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1159\/000490526","article-title":"Chronic intestinal pseudo-obstruction in systemic sclerosis: an uncommon presentation","volume":"12","author":"Shah J","year":"2018","unstructured":"Shah J, Shahidullah A. Chronic intestinal pseudo-obstruction in systemic sclerosis: an uncommon presentation. Case Rep Gastroenterol. 2018, 12:373-8. 10.1159\/000490526","journal-title":"Case Rep Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg170","article-title":"The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis","volume":"42","author":"Hesselstrand R","year":"2003","unstructured":"Hesselstrand R, Scheja A, Shen GQ, Wiik A, Akesson A. The association of antinuclear antibodies with organ involvement and survival in systemic sclerosis. Rheumatology (Oxford). 2003, 42:534-40. 10.1093\/rheumatology\/keg170","journal-title":"Rheumatology (Oxford)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-018-4977-8","article-title":"Intestinal involvement in systemic sclerosis: a clinical review","volume":"63","author":"Sakkas LI","year":"2018","unstructured":"Sakkas LI, Simopoulou T, Daoussis D, Liossis SN, Potamianos S. Intestinal involvement in systemic sclerosis: a clinical review. Dig Dis Sci. 2018, 63:834-44. 10.1007\/s10620-018-4977-8","journal-title":"Dig Dis Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.096545","article-title":"Muscarinic-3 acetylcholine receptor autoantibody in patients with systemic sclerosis: contribution to severe gastrointestinal tract dysmotility","volume":"68","author":"Kawaguchi Y","year":"2009","unstructured":"Kawaguchi Y, Nakamura Y, Matsumoto I, et al.. Muscarinic-3 acetylcholine receptor autoantibody in patients with systemic sclerosis: contribution to severe gastrointestinal tract dysmotility. Ann Rheum Dis. 2009, 68:710-4. 10.1136\/ard.2008.096545","journal-title":"Ann Rheum Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-017-1445-4","article-title":"Hidebound bowel sign","volume":"43","author":"Leshchinskiy S","year":"2018","unstructured":"Leshchinskiy S, D'Agostino R. Hidebound bowel sign. Abdom Radiol (NY). 2018, 43:2513-6. 10.1007\/s00261-017-1445-4","journal-title":"Abdom Radiol (NY)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.14715","article-title":"Chronic intestinal pseudo-obstruction in adults: a practical guide to identify patient subgroups that are suitable for more specific treatments","volume":"36","author":"Basilisco G","year":"2024","unstructured":"Basilisco G, Marchi M, Coletta M. Chronic intestinal pseudo-obstruction in adults: a practical guide to identify patient subgroups that are suitable for more specific treatments. Neurogastroenterol Motil. 2024, 36:10.1111\/nmo.14715","journal-title":"Neurogastroenterol Motil"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2147\/CEG.S249877","article-title":"Recent advances in the management of severe gastrointestinal dysmotility","volume":"14","author":"Vasant DH","year":"2021","unstructured":"Vasant DH, Lal S. Recent advances in the management of severe gastrointestinal dysmotility. Clin Exp Gastroenterol. 2021, 14:163-72. 10.2147\/CEG.S249877","journal-title":"Clin Exp Gastroenterol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.13937","article-title":"An international survey on clinicians' perspectives on the diagnosis and management of chronic intestinal pseudo-obstruction and enteric dysmotility","volume":"32","author":"Vasant DH","year":"2020","unstructured":"Vasant DH, Pironi L, Barbara G, et al.. An international survey on clinicians' perspectives on the diagnosis and management of chronic intestinal pseudo-obstruction and enteric dysmotility. Neurogastroenterol Motil. 2020, 32:10.1111\/nmo.13937","journal-title":"Neurogastroenterol Motil"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s11894-017-0565-x","article-title":"Small bowel motility","volume":"19","author":"Malagelada C","year":"2017","unstructured":"Malagelada C, Malagelada JR. Small bowel motility. Curr Gastroenterol Rep. 2017, 19:10.1007\/s11894-017-0565-x","journal-title":"Curr Gastroenterol Rep"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00693.x","article-title":"Low-dose intravenous erythromycin: effects on postprandial and fasting motility of the small bowel","volume":"14","author":"Medhus AW","year":"2000","unstructured":"Medhus AW, Bondi J, Gaustad P, Husebye E. Low-dose intravenous erythromycin: effects on postprandial and fasting motility of the small bowel. Aliment Pharmacol Ther. 2000, 14:233-40. 10.1046\/j.1365-2036.2000.00693.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04907.x","article-title":"Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction - a double-blind, placebo-controlled, cross-over, multiple n = 1 study","volume":"35","author":"Emmanuel AV","year":"2012","unstructured":"Emmanuel AV, Kamm MA, Roy AJ, Kerstens R, Vandeplassche L. Randomised clinical trial: the efficacy of prucalopride in patients with chronic intestinal pseudo-obstruction - a double-blind, placebo-controlled, cross-over, multiple n = 1 study. Aliment Pharmacol Ther. 2012, 35:48-55. 10.1111\/j.1365-2036.2011.04907.x","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/442087-systemic-sclerosis-related-intestinal-pseudo-obstruction-mimicking-mechanical-small-bowel-obstruction","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T14:28:41Z","timestamp":1768746521000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/442087-systemic-sclerosis-related-intestinal-pseudo-obstruction-mimicking-mechanical-small-bowel-obstruction"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,18]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.101784","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,18]]}}}